Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miao Mo

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Cancer Medicine|November 28, 2018
Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancerNai-Si Huang, Xing-Xing Chen, Wen-Jun Wei, et al.
Eclinicalmedicine|February 15, 2024
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trialDashan Ai, Shengnan Hao, Wenbin Shen, et al.
BMC Cancer|January 9, 2024
Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trialLi Zhang, Xin Mei, Zhigang Hu, et al.
Pathology, Research and Practice|January 1, 2020
The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinomaFeng Zhong, Hui-Ping Lu, Gang Chen, et al.
Radiation Oncology (London, England)|July 29, 2022
Dose escalation based on <sup>18</sup>F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)Hongcheng Zhu, Qiufang Liu, Hao Xu, et al.
Oncology Letters|November 6, 2020
The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinomaFeng Zhong, Hui-Ping Lu, Gang Chen, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trialKe-Da Yu, Xi-Yu Liu, Li Chen, et al.
Springerplus|August 21, 2013
Performance of breast cancer screening methods and modality among Chinese women: a report from a society-based breast screening program (SBSP) in ShanghaiMiao Mo, Guang-Yu Liu, Ying Zheng, et al.
JAMA Network Open|February 21, 2022
Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer: A Randomized Clinical TrialDashan Ai, Jinjun Ye, Shihong Wei, et al.
The Lancet. Oncology|July 28, 2024
Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trialXin Liu, Xiaowei Zhang, Shiyu Jiang, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Cancer Medicine|November 28, 2018
Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancerNai-Si Huang, Xing-Xing Chen, Wen-Jun Wei, et al.
Eclinicalmedicine|February 15, 2024
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trialDashan Ai, Shengnan Hao, Wenbin Shen, et al.
BMC Cancer|January 9, 2024
Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trialLi Zhang, Xin Mei, Zhigang Hu, et al.
Pathology, Research and Practice|January 1, 2020
The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinomaFeng Zhong, Hui-Ping Lu, Gang Chen, et al.
Radiation Oncology (London, England)|July 29, 2022
Dose escalation based on <sup>18</sup>F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)Hongcheng Zhu, Qiufang Liu, Hao Xu, et al.
Oncology Letters|November 6, 2020
The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinomaFeng Zhong, Hui-Ping Lu, Gang Chen, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trialKe-Da Yu, Xi-Yu Liu, Li Chen, et al.
Springerplus|August 21, 2013
Performance of breast cancer screening methods and modality among Chinese women: a report from a society-based breast screening program (SBSP) in ShanghaiMiao Mo, Guang-Yu Liu, Ying Zheng, et al.
JAMA Network Open|February 21, 2022
Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer: A Randomized Clinical TrialDashan Ai, Jinjun Ye, Shihong Wei, et al.
The Lancet. Oncology|July 28, 2024
Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trialXin Liu, Xiaowei Zhang, Shiyu Jiang, et al.
Pageof 13